COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 29, 2016
app pub date -
Nov 25, 2014
filing date -
Nov 27, 2013
priority date (Note) -
Published
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance

US Family Size
|
Non-US Coverage
|
Abstract
The present invention relates to a pharmaceutical combination which comprises (a) a JAK inhibitor compound, (b) a CDK inhibitor, and (c) a PIM kinase inhibitor compound, and optionally, at least one pharmaceutically acceptable carrier for simultaneous, separate or sequential use, in particular for the treatment of a myeloid neoplasm or leukemia; a pharmaceutical composition comprising such a combination; the use of such a combination for the preparation of a medicament for the treatment of myeloid neoplasm or leukemia; a commercial package or product comprising such a combination as a combined preparation for simultaneous, separate or sequential use; and to a method of treatment of a mammal, especially a human.
First Claim
all claims..Other Claims data not available
Family
Country | kind | publication No. | Filing Date | Type | Sub-Type |
---|---|---|---|---|---|
JP | A | JP2016538305 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
Published unexamined patent application | JAK、CDKおよびPIMの阻害剤を含む組合せ療法 | Dec 08, 2016 | |||
CN | A | CN105764528 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
UNEXAMINED APPLICATION FOR A PATENT FOR INV. | Combination therapy comprising an inhibitor of JAK, CDK and PIM | Jul 13, 2016 | |||
WO | A1 | WO2015081083 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
INTERNATIONAL APPLICATION PUBLISHED WITH INTERNATIONAL SEARCH REPORT | COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK AND PIM | Jun 04, 2015 | |||
MX | A | MX2016006894 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
PATENT APPLICATION | TERAPIA DE COMBINACION QUE COMPRENDE UN INHIBIDOR DE JAK, CDK Y PIM. | Aug 17, 2016 | |||
KR | A | KR20160090814 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
UNEXAMINED PATENT APPLICATION | JAK, CDK 및 PIM의 억제제를 포함하는 조합 요법 | Aug 01, 2016 | |||
AU | A1 | AU2014354821 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
OPEN TO PUBLIC INSPECTION | Combination therapy comprising an inhibitor of JAK, CDK and PIM | May 26, 2016 | |||
EP | A1 | EP3074043 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION PUBLISHED WITH SEARCH REPORT | COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK AND PIM | Oct 05, 2016 | |||
RU | A | RU2016125133 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
LAID OPEN PATENT APPLICATION | КОМБИНИРОВАННАЯ ТЕРАПИЯ, ВКЛЮЧАЮЩАЯ ПРИМЕНЕНИЕ ИНГИБИТОРОВ JAK, CDK И PIM | Jan 09, 2018 | |||
CA | A1 | CA2929620 | Nov 25, 2014 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
APPLICATION LAID OPEN | COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK AND PIM | Jun 04, 2015 | |||
US | A1 | US20180071296 | Sep 20, 2017 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
FIRST PUBLISHED PATENT APPLICATION | COMBINATION THERAPY COMPRISING AN INHIBITOR OF JAK, CDK, AND PIM | Mar 15, 2018 | |||
AU | A1 | AU2017245332 | Oct 11, 2017 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
OPEN TO PUBLIC INSPECTION | Combination therapy comprising an inhibitor of JAK, CDK and PIM | Nov 02, 2017 | |||
AU | A1 | AU2018256668 | Nov 02, 2018 | Patent | Application |
Type : Patent Sub-Type : Application | |||||
OPEN TO PUBLIC INSPECTION | Combination therapy comprising an inhibitor of JAK, CDK and PIM | Nov 22, 2018 |
- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
NOVARTIS AG | LICHTSTRASSE 35 BASEL 4056 |
International Classification(s)

- 2014 Application Filing Year
- A61K Class
- 14144 Applications Filed
- 11600 Patents Issued To-Date
- 82.02 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
CAO, Zhu Alexander | Acton, US | 17 | 232 |
# of filed Patents : 17 Total Citations : 232 | |||
PINZON-ORTIZ, Maria | Upton, US | 3 | 0 |
# of filed Patents : 3 Total Citations : 0 | |||
RONG, Xianhui | Boxborough, US | 5 | 155 |
# of filed Patents : 5 Total Citations : 155 |
Cited Art Landscape
- No Cited Art to Display

Patent Citation Ranking
- 0 Citation Count
- A61K Class
- 0 % this patent is cited more than
- 9 Age
Forward Cite Landscape
- No Forward Cites to Display

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 29, 2028 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text

Legal Events
- No Legal Status data available.

Matter Detail

Renewals Detail
